SCHEMBL11560713

SCHEMBL11560713

CCc1cccc(Cl)c1N(CC)C(=O)N(CCOC)C(=N)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.41
▸ NR1I2 O75469 1/20 0.40
▸ KMT2A Q03164 4/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ TSHR P16473 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ RAB9A P51151 1/20 0.32
▸ GLA P06280 2/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ S1PR1 P21453 1/20 0.31
▸ CRHR1 P34998 1/20 0.31
▸ RORC P51449 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11557122 0.92 TP53 (0.45) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11563452 0.89 KDM4E (0.36) TP53KMT2ATDP1MEN1HPGD
SCHEMBL11561630 0.88 NR1I2 (0.41) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11554505 0.87 TP53 (0.44) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11561213 0.87 TP53 (0.39) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11554270 0.87 TP53 (0.38) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11564840 0.86 NR1I2 (0.39) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11559887 0.85 NR1I2 (0.41) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11560747 0.83 TP53 (0.44) TP53NR1I2KMT2ATDP1MEN1
SCHEMBL11560799 0.82 NR1I2 (0.41) TP53NR1I2KMT2ATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4147804-A ANTIARRHYTHMIA AGENTS WILLIAM H. RORER, INC. (US) 1979-04-03 — — US disclosed
Send feedback